Delivery Order SPE2DB22D3016-SPE2DB24FBCK2

Award Date 7/29/24
Potential Completion Date 8/19/24
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG vials. The contract has a ceiling value of $7,499.79 and runs through November 4, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. As a key supplier of pharmaceutical and medical products to the federal government, including military treatment facilities and veterans' healthcare...
This is a federal delivery order contract awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,695.90 firm-fixed-price contract is for the delivery of PADCEV 20 MG VIAL 1S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is not set aside for any small business or socioeconomic program. AmerisourceBergen Drug Corp also holds a much larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PADCEV 30 MG VIALS, with a ceiling value of $11,087.60 and a completion date of May 5, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $14,999.58 firm-fixed price contract is for the delivery of PADCEV 30 MG Vials, a pharmaceutical product. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This single-award IDC serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PADCEV 30 MG vials, a pharmaceutical product. The contract has a ceiling value of $22,175.20 and a completion date of June 12, 2025. It is a Firm Fixed Price contract and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of PADCEV 30 MG VIALS. The contract has a ceiling value of $8,315.70 and a period of performance through January 30, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,345.32, is for the delivery of PADCEV 30 MG vials. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 30, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PADCEV 30 MG VIALS, a pharmaceutical product. The contract has a ceiling value of $8,315.70 and is a firm fixed-price delivery order contract, with a period of performance ending on July 16, 2025. The contract is not set-aside and was awarded on June 24, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG vials. The contract has a ceiling value of $8,315.70 and a period of performance through July 25, 2025. This award is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $14,999.58 firm fixed price contract is for the supply of 4565900198 - PADCEV 30 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to federal agencies, including the military, and holds several Indefinite...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBCK2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of PADCEV 30 MG VIALS, a pharmaceutical product. The contract has a firm fixed price of $7,499.79 and a period of performance through August 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is supplying these critical medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries through this contract. The award is not associated with a set-aside program and is part of AmerisourceBergen's broader portfolio of federal contracts, which includes Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for providing a range of pharmaceutical and medical supplies to various government agencies and healthcare facilities.

Generated 10/28/24, 9:43 AM